Regencell Bioscience (NASDAQ:RGC) Bolsa

Regal Entertainment Group Class A Common Stock

Regal Entertainment

Regal Entertainment Group

NYSE

Regencell Bioscience

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AGMH

ANTE

ARBE

ARLO

ATXI

Bakkt Holdings, Inc. Class A Common Stock

BKKT

FINV

GNPX

GRAB

HNRG

HROW

HYPR

KTCC

VRPX

VSTM

Las acciones de Harrow subieron un 23,1% en el premercado. Descubre qué otras compañías están ganando y perdiendo antes de la apertura.

Las acciones de Harrow (HROW) se disparan un 23%; aquí están 20 acciones que se mueven en el premercado

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience Holdings Ltd

Relevant Gold Corp

RGC Resources Inc

U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Wednesday.
Shares of GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) rose sharply during Wednesday's session after the company posted better-than-expected second-quarter 2025 earnings and <a href="https://www.benzinga.com/markets/earnings/25/07/46570983/ge-vernova-lifts-outlook-as-revenue-and-orders-surge">raised its full-year guidance</a>.
The energy transition company reported second-quarter earnings per share of $1.86, beating the consensus estimate of $1.69. Revenue came in at $9.11 billion, exceeding Wall Street's expectations of $8.78 billion.
GE Vernova shares climbed 13.5% to $623.10 on Wednesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>ABIVAX Société Anonyme (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVX#NASDAQ">ABVX</a>) shares jumped 548% to $66.13 after the company announced that Obefazimod met all its key secondary endpoints. JMP Securities raised its price target on the stock from $33 to $39.</li>
<li>aTyr Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATYR#NASDAQ">ATYR</a>) gained 31.7% to $6.90.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) rose 28% to $4.0050. Chardan Capital maintained a Buy rating on the stock.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) gained 23% to $16.73.</li>
<li>Lamb Weston Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) jumped 19.6% to $58.78 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) rose 19.2% to $124.93 after the company reported fourth-quarter financial results and beat its EPS and revenue estimates.</li>
<li>Vicor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VICR#NASDAQ">VICR</a>) rose 18.7% to $53.66 following second-quarter results.</li>
<li>Liberty Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LBRT#NYSE">LBRT</a>) gained 18.5% to $13.34 after the company and Oklo announced an alliance to offer an integrated deployment strategy.</li>
<li>Humacyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) rose 18% to $2.7150 after the company announced the first Symvess sale to a U.S. military treatment facility.</li>
<li>Valneva SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALN#NASDAQ">VALN</a>) climbed 17.5% to $7.32.</li>
<li>Krispy Kreme, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNUT#NASDAQ">DNUT</a>) gained 16.2% to $4.80. The stock's sudden rise appears to be driven by retail investors, with the company gaining increased attention on various social media platforms.</li>
<li>Toyota Motor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) climbed 13.3% to $192.68. Shares of US-listed Japanese stocks traded higher after President Trump announced a trade deal with Japan.</li>
<li>Thermo Fisher Scientific Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) rose 12.7% to $481.78 after the company reported better-than-expected quarterly financial results.</li>
<li>Honda Motor Co., Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMC#NYSE">HMC</a>) gained 12.5% to $34.19. Shares of US-listed Japanese stocks traded higher after President Trump announced a trade deal with Japan.</li>
<li>Pegasystems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) rose 10% to $56.03 after the company reported second-quarter financial results and beat its adjusted EPS and revenue estimates.</li>
<li>Manhattan Associates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) gained 10% to $223.06 after the company reported better-than-expected second-quarter financial results and raised its FY25 guidance above estimates.</li>
<li>Lennox International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) jumped 10% to $682.00 following upbeat second-quarter results.</li>
<li>Arrowhead Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARWR#NASDAQ">ARWR</a>) jumped 9.8% to $16.43 fter the company issued a statement reaffirming the strength of its exclusive license and collaboration agreement with Sarepta Therapeutics.</li>
<li>Stellantis N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) rose 9.6% to $10.16.</li>
<li>General Dynamics Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) gained 6.4% to $316.80 after the company reported better-than-expected second-quarter financial results.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/07/46541326/wall-streets-most-accurate-analysts-weigh-in-on-3-industrials-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Industrials Stocks With Over 5% Dividend Yields</a></li>
</ul>
Photo via Shutterstock

Earnings

ABVX

ARWR

ATYR

CALM

DNUT

HUMA

IOVA

LBRT

MANH

PEGA

STLA

VALN

VICR

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were mixed, with the Dow Jones index falling over 100 points on Tuesday.
Shares of Microchip Technology Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) rose sharply during <a href="https://www.benzinga.com/quote/MCHP">Tuesday's session</a>.
Mizuho analyst Vijay Rakesh maintained Microchip Technology with an Outperform rating and raised the price target from $78 to $85.
Microchip Technology shares jumped 4.1% to $74.36 on Tuesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Humacyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) shares jumped 27.4% to $2.7690. Humacyte announced Symvess has been awarded Electronic Catalog Listing approval from the US Defense Logistics Agency.</li>
<li>Wolfspeed, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) rose 18.2% to $2.7300 after nearly doubling on Monday. Wolfspeed shares have soared in recent sessions as investors anticipate a potential turnaround for the company after it filed for Chapter 11 bankruptcy last week.</li>
<li>SharpLink Gaming, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) gained 16.4% to $14.75. SharpLink Gaming announced the acquisition of an additional 7,689 ETH for the week June 28 through July 4, 2025.</li>
<li>SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) jumped 16.4% to $13.28.</li>
<li>Bitmine Immersion Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#NYSE">BMNR</a>) shares rose 16% to $124.66.</li>
<li>QuantumScape Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) climbed 15.2% to $8.07.</li>
<li>Opendoor Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPEN#NASDAQ">OPEN</a>) gained 14% to $0.7153. Opendoor Technologies will report second quarter 2025 financial results for the period ended June 30, following the close of the market on Tuesday, Aug. 5.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) surged 13.2% to $20.87.</li>
<li>Anbio Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNNN#NASDAQ">NNNN</a>) rose 13% to $44.45.</li>
<li>Recursion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) gained 12.8% to $5.57.</li>
<li>Moderna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) rose 9.4% to $32.73.</li>
<li>Shinhan Financial Group Co., Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHG#NYSE">SHG</a>) gained 8.8% to $50.44.</li>
<li>Concentrix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) rose 7.7% to $61.05.</li>
<li>Albemarle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) shares rose 7.6% to $70.47.</li>
<li>The Goodyear Tire &amp; Rubber Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>) gained 7.3% to $11.69.</li>
<li>Woori Financial Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WF#NYSE">WF</a>) rose 7% to $54.09.</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) rose 5.7% to $23.26.</li>
<li>Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) gained 5.7% to $29.05. Dow announced it will shut down three European plants, which may result in up to $790 million worth of asset write-downs.</li>
<li>Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) rose 4.7% to $60.79. Celanese announced that it will host a conference call to discuss its second quarter results on Tuesday, August 12.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) gained 3.1% to $303.14. Tesla CEO Elon Musk recently announced plans to launch a new political party. Wedbush analyst Daniel Ives reiterated Tesla with an Outperform rating and maintained a $500 price target, while Mizuho analyst Vijay Rakesh maintained the stock with an Outperform rating and lowered the price target from $390 to $375.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/07/46296955/meta-platforms-to-rally-around-9-here-are-10-top-analyst-forecasts-for-tuesday">Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday</a> </li>
</ul>
Photo via Shutterstock

BMNR

CNXC

INTC

MCHP

MRNA

NNNN

OPEN

RXRX

SBET

SOUN

TSLA

WOLF

Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday

Shares of Apogee Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APGE#NASDAQ">APGE</a>) rose sharply in today's pre-market trading after the company disclosed positive 16-week data from Phase 2 APEX clinical trial of APG777, its potentially best-in-class anti-IL-13 antibody, in moderate-to-severe atopic <a href="https://www.benzinga.com/quote/APOG">dermatitis</a>.
Apogee Therapeutics shares jumped 50% to $71.19 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>Mullen Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) surged 80.2% to $0.4030 in pre-market trading. Mullen Automotive recently announced it is now accepting Bitcoin and TRUMP Coin for EV purchases.</li>
<li>Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) gained 52.2% to $5.97 in pre-market trading after falling more than 5% on Thursday.</li>
<li>MediaCo Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDIA#NASDAQ">MDIA</a>) rose 32.7% to $1.46 in pre-market trading after falling 3% on Thursday.</li>
<li>Inno Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INHD#NASDAQ">INHD</a>) climbed 28% to $1.51 in pre-market trading after dipping 19% on Thursday.</li>
<li>Northern Dynasty Minerals Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NAK#NYSE">NAK</a>) jumped 23.9% to $1.74 in pre-market trading.</li>
<li>K Wave Media Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KWM#NASDAQ">KWM</a>) gained 17.6% to $5.06 in pre-market trading after gaining 13% on Thursday.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) gained 14% to $26.20 in pre-market trading after jumping 122% on Thursday.</li>
<li>WNS (Holdings) Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) gained 12.9% to $73.90 in pre-market trading after Capgemini SE (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CGEMY#OTC">CGEMY</a>) announced that it will acquire WNS Holdings in a $3.3 billion all-cash deal to create a global leader in Agentic AI-powered Intelligent Operations.</li>
<li>So-Young International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SY#NASDAQ">SY</a>) gained 10.8% to $3.60.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Bitmine Immersion Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#NYSE">BMNR</a>) shares tumbled 19.3% to $110.00 in pre-market trading. BitMine Immersion Technologies shares jumped over 130% on Thursday after the company on Monday announced a $250 million private placement to launch an Ethereum treasury strategy..</li>
<li>Enigmatig Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGG#NYSE">EGG</a>) fell 17% to $4.72 in pre-market trading after gaining around 54% on Thursday.</li>
<li>Lixte Biotechnology Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) dipped 15.2% to $2.40 in pre-market trading after gaining 40% on Thursday.</li>
<li>MingZhu Logistics Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) declined 14.7% to $0.87 in pre-market trading. MingZhu Logistics entered into share purchase agreement to acquire Mingzhuchun.</li>
<li>Powell Max Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMAX#NASDAQ">PMAX</a>) dipped 13.2% to $0.4450 in pre-market trading after gaining 4% on Thursday.</li>
<li>Quantum-Si incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) fell 10.3% to $1.92 in pre-market trading after the company announced the pricing of $50 million registered direct offering of common stock.</li>
<li>XORTX Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRTX#NASDAQ">XRTX</a>) fell 10.1% to $0.8097 in pre-market trading following a 10% decline on Thursday.</li>
<li>Webull Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>) declined 9.5% to $12.95 in pre-market trading.</li>
<li>XTL Biopharmaceuticals Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTLB#NASDAQ">XTLB</a>) shares fell 8.3% to $1.21 in pre-market trading after gaining 10% on Thursday.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell 6.4% to $295.32 in pre-market trading amid the billionaire&#8217;s feud with President Donald Trump, which began over the latter&#8217;s "Big, Beautiful Bill."</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46243448/cramer-doesnt-recommend-titan-international-joby-aviation-soars-after-milestone-flight">Cramer Doesn&#8217;t Recommend Titan International, Joby Aviation Soars After Milestone Flight</a> </li>
</ul>
Photo via Shutterstock

APGE

APOG

BULL

CGEMY

INHD

LIXT

MDIA

MULN

PMAX

SONN

XRTX

XTLB

YGMZ

Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) stock increased by 13.8% to $4.46 during Thursday's after-market session. The company's market cap stands at $13.1 million. </li>
<li>Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) shares increased by 11.11% to $0.45. The company's market cap stands at $20.7 million. </li>
<li>NeOnc Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTHI#NASDAQ">NTHI</a>) shares rose 10.29% to $6.43. The company's market cap stands at $100.6 million. </li>
<li>ProKidney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) stock rose 9.85% to $0.7. The company's market cap stands at $74.9 million. </li>
<li>Beta Bionics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBNX#NASDAQ">BBNX</a>) stock rose 9.17% to $14.76. The market value of their outstanding shares is at $613.0 million. </li>
<li>Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) shares moved upwards by 9.02% to $1.45. The company's market cap stands at $78.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lixte Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) stock declined by 16.6% to $2.36 during Thursday's after-market session. The company's market cap stands at $5.5 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares declined by 14.97% to $19.55. The company's market cap stands at $5.1 billion. As per the news, the H1 earnings report came out 3 days ago. </li>
<li>Indaptus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDP#NASDAQ">INDP</a>) stock decreased by 9.09% to $10.11. The company's market cap stands at $6.1 million. </li>
<li>Coherus Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRS#NASDAQ">CHRS</a>) shares declined by 8.62% to $0.74. The company's market cap stands at $92.1 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares decreased by 6.38% to $0.87. The market value of their outstanding shares is at $2.8 million. </li>
<li>Trinity Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIB#NASDAQ">TRIB</a>) shares decreased by 5.87% to $0.71. The market value of their outstanding shares is at $13.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBNX

CGTX

CHRS

INDP

NTHI

PROK

TRIB

WINT

12 Health Care Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) stock moved upwards by 120.3% to $22.82 during Thursday's regular session. The market value of their outstanding shares is at $5.1 billion. As per the news, the H1 earnings report came out 3 days ago. </li>
<li>Lixte Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) shares increased by 41.48% to $2.86. The market value of their outstanding shares is at $5.5 million. </li>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) stock moved upwards by 31.37% to $1.91. The market value of their outstanding shares is at $181.1 million. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) shares rose 31.14% to $1.56. The company's market cap stands at $39.3 million. </li>
<li>Know Labs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KNW#AMEX">KNW</a>) stock rose 27.97% to $2.47. The market value of their outstanding shares is at $14.3 million. </li>
<li>Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) stock moved upwards by 23.53% to $0.41. The market value of their outstanding shares is at $20.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) shares declined by 37.9% to $1.33 during Thursday's regular session. The company's market cap stands at $78.4 million. </li>
<li>Jyong Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MENS#NASDAQ">MENS</a>) shares decreased by 17.68% to $7.92. The company's market cap stands at $731.3 million. </li>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) shares decreased by 11.74% to $0.56. The company's market cap stands at $28.4 million. </li>
<li>GT Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTBP#NASDAQ">GTBP</a>) stock fell 11.34% to $2.75. The company's market cap stands at $9.7 million. </li>
<li>Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) stock fell 10.54% to $2.64. The market value of their outstanding shares is at $5.4 million. </li>
<li>Zynex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>) shares declined by 10.41% to $2.41. The company's market cap stands at $81.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GTBP

JUNS

MENS

ONMD

VERO

ZYXI

12 Health Care Stocks Moving In Thursday's Intraday Session

U.S. stocks were higher, with the Dow Jones index gaining over 200 points on Thursday.
Shares of Olo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLO#NYSE">OLO</a>) rose sharply during Thursday's session after the company announced that it entered into a definitive agreement to be <a href="https://www.benzinga.com/quote/OLO">acquired by Thoma Bravo</a>.
Olo shares jumped 13.5% to $10.11 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares jumped 48.8% to $15.41.</li>
<li>Bitmine Immersion Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#NYSE">BMNR</a>) gained 36% to $80.00.</li>
<li>Concorde International Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIGL#NASDAQ">CIGL</a>) gained 21.7% to $22.68.</li>
<li>Tripadvisor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIP#NASDAQ">TRIP</a>) jumped 18% to $17.70 after activist investor Starboard Value acquired a 9% stake in the company.</li>
<li>DeFi Development Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFDV#NASDAQ">DFDV</a>) rose 16.4% to $23.71. DeFi Development purchased 17,760 SOL.</li>
<li>Aebi Schmidt Holding AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEBI#NASDAQ">AEBI</a>) gained 16.4% to $13.01 after making its Nasdaq debut following its merger with the Shyft Group.</li>
<li>So-Young International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SY#NASDAQ">SY</a>) gained 15.6% to $3.85. So-Young regained compliance with Nasdaq Minimum Bid Price Requirement.</li>
<li>Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) jumped 13% to $10.16.</li>
<li>Datadog, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) gained 11.88% to $150.98 after it was announced the company is set to join the S&amp;P 500.</li>
<li>TMC the metals company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) rose 10.3% to $7.03.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) rose 8.6% to $45.85.</li>
<li>GDS Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) jumped 8.4% to $33.39.</li>
<li>First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) gained 8.4% to $184.79.</li>
<li>Lucid Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) rose 5.6% to $2.1650 after the company reported second-quarter production of 3,863 vehicles and deliveries of 3,309.</li>
</ul>
Now Read This:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46218519/jim-cramer-gives-utilities-stock-a-week-says-doge-not-done-clobbering-booz-allen">Jim Cramer Gives Utilities Stock &#8216;A Week,&#8217; Says DOGE &#8216;Not Done Clobbering&#8217; Booz Allen</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

AEBI

CIGL

DDOG

DFDV

FSLR

LCID

TRIP

Olo, Tripadvisor, Aebi Schmidt Holding And Other Big Stocks Moving Higher On Thursday

<h3>Gainers</h3>
<ul>
<li>Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) stock moved upwards by 82.6% to $2.21 during Wednesday's regular session. The market value of their outstanding shares is at $3.8 million. </li>
<li>Lixte Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) stock moved upwards by 49.15% to $1.76. The market value of their outstanding shares is at $3.2 million. </li>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) shares moved upwards by 40.9% to $14.88. The market value of their outstanding shares is at $53.9 million. </li>
<li>NeOnc Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTHI#NASDAQ">NTHI</a>) stock increased by 31.34% to $4.4. The company's market cap stands at $63.7 million. </li>
<li>Nutriband (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRB#NASDAQ">NTRB</a>) shares moved upwards by 27.93% to $10.26. The market value of their outstanding shares is at $89.2 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares moved upwards by 25.39% to $0.69. The company's market cap stands at $2.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Centene (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) shares decreased by 39.6% to $34.19 during Wednesday's regular session. The market value of their outstanding shares is at $28.1 billion. </li>
<li>Mustang Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) stock decreased by 38.44% to $1.26. The company's market cap stands at $8.9 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares decreased by 27.37% to $10.61. The company's market cap stands at $7.2 billion. As per the news, the H1 earnings report came out 2 days ago. </li>
<li>CytoSorbents (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSO#NASDAQ">CTSO</a>) stock declined by 25.82% to $0.96. The market value of their outstanding shares is at $80.7 million. </li>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) stock declined by 20.43% to $0.27. The market value of their outstanding shares is at $7.9 million. </li>
<li>Molina Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) shares declined by 20.18% to $244.5. The market value of their outstanding shares is at $16.6 billion. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTSO

CYCC

EYEN

MBIO

NTRB

12 Health Care Stocks Moving In Wednesday's Intraday Session

Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) reported quarterly losses of $(0.36) per share. This is a 14.29 percent increase over losses of $(0.42) per share from the same period last year.

Regencell Bioscience H1 EPS $(0.36) Up From $(0.42) YoY

Shares of BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) rose sharply in today's pre-market trading following <a href="https://www.benzinga.com/markets/earnings/25/06/46084802/blackberry-stock-climbs-after-better-than-expected-q1-report-details">first-quarter results</a>.
BlackBerry reported quarterly earnings of two cents per share, which beat the analyst consensus estimate of zero cents. Quarterly revenue of $121.7 million beat the Street estimate of $112.18 million.
The company raised its fiscal 2026 revenue guidance from a range of $504 million to $534 million to a new range of between $508 million and $538 million, versus the $513.51 million estimate.
BlackBerry shares jumped 14.7% to $4.96 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>NaaS Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) surged 40.6% to $1.08 in pre-market trading after gaining 4% on Tuesday.</li>
<li>QuantumScape Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) gained 31.1% to $5.66 in pre-market trading after the company achieved a key 2025 milestone by successfully integrating its advanced Cobra separator process into baseline cell production.</li>
<li>Beeline Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNE#NASDAQ">BLNE</a>) gained 27.5% to $1.81 in pre-market trading after jumping 29% on Tuesday.</li>
<li>Liminatus Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) rose 22.5% to $32.70 in pre-market trading after jumping over 33% on Tuesday.</li>
<li>Genius Group Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNS#NYSE">GNS</a>) jumped 20.8% to $0.8152 in pre-market trading after gaining more than 30% on Tuesday.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) climbed 14.6% to $26.30 in pre-market trading.</li>
<li>Impact BioMedical Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBO#NYSE">IBO</a>) gained 13.2% to $0.9566 in pre-market trading after dipping 48% on Tuesday. Impact BioMedical recently announced a limited merger and share exchange agreement with Dr Ashleys.</li>
<li>UP Fintech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) rose 14.2% to $9.30 in pre-market trading.</li>
<li>Worthington Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>) gained 10.5% to $66.44 in pre-market trading as the company reported better-than-expected fourth-quarter financial results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>XTI Aerospace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTIA#NASDAQ">XTIA</a>) shares tumbled 31.2% to $1.92 in pre-market trading after the company announced the pricing of $16 million public offering.</li>
<li>Torrid Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAAS#NASDAQ">MAAS</a>) shares fell 29.2% to $3.61 in pre-market trading.</li>
<li>FAST TRACK GROUP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRK#NASDAQ">FTRK</a>) dipped 19.2% to $2.01 in pre-market trading after dipping 60% on Tuesday.</li>
<li>OneMedNet Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) declined 14.3% to $0.5850 in pre-market trading. OneMedNet shares jumped over 100% on Tuesday after the company entered into private placement agreements with accredited investors raising approximately $3.7 million in gross proceeds.</li>
<li>InspireMD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSPR#NASDAQ">NSPR</a>) dipped 12.1% to $2.19 in pre-market trading after the company received FDA premarket application approval for CGuard Prime Carotid Stent System.</li>
<li>Greenlane Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) fell 11.2% to $0.0079 in pre-market trading. Greenlane announced a 1-for-750 reverse stock split, effective on June 26.</li>
<li>XTL Biopharmaceuticals Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTLB#NASDAQ">XTLB</a>) declined 11.1% to $1.16 in pre-market trading after gaining 28% on Tuesday.</li>
<li>Allot Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLT#NASDAQ">ALLT</a>) fell 9% to $8.75 in pre-market trading after the company announced the pricing of underwritten public offering of ordinary shares.</li>
<li>Cidara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) fell 6.6% to $43.75 in pre-market trading after the company announced the pricing of upsized public offering of common stock.</li>
<li>FedEx Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) fell 5.4% to $216.85 in pre-market trading following soft first-quarter guidance.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46072226/top-3-real-estate-stocks-you-may-want-to-dump-in-june"> </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46072226/top-3-real-estate-stocks-you-may-want-to-dump-in-june">Top 3 Real Estate Stocks You May Want To Dump In June</a> </li>
</ul>
Photo via Shutterstock

ALLT

BLNE

CDTX

FTRK

GNLN

LIMN

Highest Performances Holdings Inc. - American Depository Shares

MAAS

NAAS

NSPR

TIGR

XTIA

Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 1% on Tuesday.
Shares of Kanzhun Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) fell sharply in today's pre-market trading after the company launched dual listing share offer of 30 million shares in Hong Kong and international markets to boost <a href="https://www.benzinga.com/quote/BZ">flexibility and investor base</a>.
Kanzhun shares dipped 2.7% to $17.20 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Upexi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPXI#NASDAQ">UPXI</a>) shares dipped 62.3% to $3.77 in pre-market trading after gaining 8% on Monday.</li>
<li>DeFi Development Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFDV#NASDAQ">DFDV</a>) fell 39.2% to $15.06 in pre-market trading. DeFi Development rescheduled release of shareholder letter and business update call to July.</li>
<li>CID HoldCo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAIC#NASDAQ">DAIC</a>) dipped 12.8% to $31.80 in pre-market trading.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares declined 8.8% to $21.62 in pre-market trading after dipping 38% on Monday.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) dropped 8.2% to $4.69 in pre-market trading.</li>
<li>Ultrapar Participações S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UGP#NYSE">UGP</a>) fell 7.4% to $2.86 in pre-market trading.</li>
<li>SS Innovations International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSII#NASDAQ">SSII</a>) dipped 5.5% to $5.34 in pre-market trading.</li>
<li>Obsidian Energy Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OBE#NYSE">OBE</a>) fell 4.7% to $5.32 in pre-market trading.</li>
<li>Advance Auto Parts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) declined 3.3% to $50.22 in pre-market trading.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46067537/blackberry-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">BlackBerry Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Photo via Shutterstock

DAIC

SSII

UPXI

Kanzhun, DeFi Development And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Shares of Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>) rose sharply in today's pre-market trading after the company announced it will release top-line data from the 16-week induction period in the ongoing global Phase 2b REZOLVE-AD clinical trial of investigational <a href="https://www.benzinga.com/quote/NKTR">rezpegaldesleukin on June 24, 2025</a>.
Nektar Therapeutics shares jumped 30.3% to $12.44 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>iBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIO#NASDAQ">IBIO</a>) surged 55.8% to $1.11 in pre-market trading after the company announced it will host a conference call to review its advances in obesity and cardiometabolic disease treatments and announce a third target in the AstralBio Collaboration in addition to Myostatin and Activin E.</li>
<li>Plus Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) gained 27.7% to $0.2354 in pre-market trading after falling 5% on Monday.</li>
<li>Korea Electric Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEP#NYSE">KEP</a>) gained 20.1% to $12.44 in pre-market trading.</li>
<li>Liminatus Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) rose 18.5% to $23.74 in pre-market trading after jumping over 38% on Monday.</li>
<li>Adial Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) jumped 17.2% to $0.3089 in pre-market trading after gaining 7% on Monday. Adial Pharmaceuticals recently announced the pricing of a $3.6 million offering.</li>
<li>Surf Air Mobility Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NASDAQ">SRFM</a>) climbed 16.2% to $2.23 in pre-market trading.</li>
<li>Rezolve AI PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLV#NASDAQ">RZLV</a>) gained 11.8% to $2.28 in pre-market trading. Rezolve AI shares gained around 6% on Monday after the company announced it will join the Russell 2000 and Russell 3000 indexes</li>
<li>WF Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFF#NASDAQ">WFF</a>) rose 9.2% to $7.10 in pre-market trading after dipping 6% on Monday.</li>
<li>Teladoc Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) gained 5.8% to $8.36 in pre-market trading. Teladoc shares surged over 14% on Monday after Citron Research made comments about the company on social media.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Upexi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPXI#NASDAQ">UPXI</a>) shares tumbled 62.3% to $3.77 in pre-market trading after gaining 8% on Monday.</li>
<li>Maase Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAAS#NASDAQ">MAAS</a>) shares fell 52.4% to $4.73 in pre-market trading after jumping over 268% on Monday.</li>
<li>DeFi Development Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFDV#NASDAQ">DFDV</a>) dipped 39.2% to $15.06 in pre-market trading. DeFi Development rescheduled release of shareholder letter and business update call to July.</li>
<li>Robin Energy Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBNE#NASDAQ">RBNE</a>) declined 26.7% to $4.91 in pre-market trading after gaining 9% on Monday.</li>
<li>Indonesia Energy Corporation Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDO#NASDAQ">INDO</a>) dipped 25.4% to $3.64 in pre-market trading after falling around 4% on Monday.</li>
<li>TMD Energy Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMDE#NYSE">TMDE</a>) fell 23.8% to $1.76 in pre-market trading after jumping 30% on Monday.</li>
<li>Impact BioMedical Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBO#NYSE">IBO</a>) declined 22.1% to $1.16 in pre-market trading. Impact BioMedical shares jumped 345% on Monday after the company announced a limited merger and share exchange agreement with Dr Ashleys.</li>
<li>Nine Energy Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NINE#NYSE">NINE</a>) fell 21.7% to $0.9160 in pre-market trading after jumping around 14% on Monday.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) fell 8.8% to $21.62 in pre-market trading after dipping 38% on Monday.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) fell 8.2% to $4.69 in pre-market trading.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46067537/blackberry-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">BlackBerry Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Photo via Shutterstock

ADIL

IBIO

INDO

NINE

NKTR

PSTV

RBNE

RZLV

SRFM

TDOC

TMDE

Why Nektar Therapeutics Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) stock moved upwards by 339.0% to $1.59 during Monday's regular session. The company's market cap stands at $4.3 million. </li>
<li>Cidara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) stock rose 100.14% to $42.07. The market value of their outstanding shares is at $272.6 million. </li>
<li>Indaptus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDP#NASDAQ">INDP</a>) shares moved upwards by 85.17% to $0.5. The company's market cap stands at $4.3 million. </li>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) stock rose 42.23% to $20.52. The company's market cap stands at $375.3 million. </li>
<li>Skye Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYE#NASDAQ">SKYE</a>) stock increased by 31.24% to $2.83. The company's market cap stands at $66.9 million. </li>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) shares increased by 31.08% to $0.32. The company's market cap stands at $30.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Compass Pathways (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) shares decreased by 46.8% to $2.46 during Monday's regular session. The market value of their outstanding shares is at $433.1 million. </li>
<li>Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares decreased by 33.13% to $42.95. The market value of their outstanding shares is at $14.3 billion. </li>
<li>Quantum BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNTM#NASDAQ">QNTM</a>) shares decreased by 32.99% to $23.45. The company's market cap stands at $101.7 million. </li>
<li>Innovative Eyewear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) stock declined by 29.86% to $2.48. The company's market cap stands at $10.9 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares decreased by 29.68% to $26.73. The company's market cap stands at $494.6 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) stock fell 27.35% to $0.41. The company's market cap stands at $2.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CMPS

Hims & Hers Health, Inc. Class A Common Stock

HIMS

LUCY

QNTM

SKYE

12 Health Care Stocks Moving In Monday's Intraday Session

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 0.1% on Monday.
Shares of Vizsla Silver Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VZLA#NASDAQ">VZLA</a>) fell sharply in today's pre-market trading after the company reported a $100 million <a href="https://www.benzinga.com/quote/vzla">bought deal financing</a>.
Vizsla Silver shares dipped 7.2% to $3.05 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Next Technology Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) shares dipped 30.2% to $2.38 in pre-market trading after jumping over 158% on Friday.</li>
<li>COMPASS Pathways plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) fell 24.4% to $3.50 in pre-market trading. Compass Pathways said it successfully achieved primary endpoint in first Phase 3 trial evaluating COMP360 psilocybin for treatment-resistant depression.</li>
<li>SS Innovations International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSII#NASDAQ">SSII</a>) fell 20.7% to $5.49 in pre-market trading after gaining around 42% on Friday.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) declined 11.9% to $33.50 in pre-market trading after dipping 40% on Friday.</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) fell 5.7% to $17.79 in pre-market trading.</li>
<li>Arqit Quantum Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQQ#NASDAQ">ARQQ</a>) fell 5.6% to $39.36 in pre-market trading after gaining 10% on Friday.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46023851/top-2-tech-stocks-that-could-sink-your-portfolio-in-june">Top 2 Tech Stocks That Could Sink Your Portfolio In June</a> </li>
</ul>
Photo via Shutterstock

ARQQ

Next Technology Holding Inc. - Ordinary Shares

NXTT

QUBT

VZLA

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Shares of Sequans Communications S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQNS#NYSE">SQNS</a>) rose sharply in today's pre-market trading after the company announced a $384 million strategic investment to launch a <a href="https://www.benzinga.com/quote/SQNS">bitcoin treasury initiative</a>.
Sequans Communications shares jumped 42.2% to $2.72 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>OceanPal Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) surged 86.1% to $2.68 in pre-market trading after dipping around 35% on Friday.</li>
<li>Indaptus Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDP#NASDAQ">INDP</a>) shares jumped 51.3% to $0.4086 in pre-market trading after tumbling 18% on Friday.</li>
<li>DIH Holding US, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHAI#NASDAQ">DHAI</a>) gained 47.5% to $0.3260 in pre-market trading.</li>
<li>Houston American Energy Corp.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUSA#NYSE">HUSA</a>) gained 30.7% to $19.41 in pre-market trading after dipping 15% on Friday.</li>
<li>Robin Energy Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBNE#NASDAQ">RBNE</a>) rose 29.5% to $7.93 in pre-market trading. Robin Energy shares dipped 30% on Friday after the company announced the pricing of a $4.0M offering of 763,000 shares at $5.25 per share.</li>
<li>TMD Energy Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDE#NASDAQ">TMDE</a>) jumped 28.2% to $2.57 in pre-market trading after falling more than 5% on Friday.</li>
<li>Exelixis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) fell 25.2% to $50.56 in pre-market trading after the company disclosed that Zanzalintinib combination with Atezolizumab achieved survival benefit in intent-to-treat population of metastatic colorectal cancer patients.</li>
<li>Zeta Global Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) climbed 17.6% to $16.67 in pre-market trading after gaining more than 12% on Friday.</li>
<li>W&amp;T Offshore, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTI#NYSE">WTI</a>) gained 9.1% to $2.36 in pre-market trading after falling 9% on Friday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>COMPASS Pathways plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) shares tumbled 30.8% to $3.20 in pre-market trading. Compass Pathways said it successfully achieved primary endpoint in first Phase 3 trial evaluating COMP360 psilocybin for treatment-resistant depression.</li>
<li>Next Technology Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) shares fell 30.2% to $2.38 in pre-market trading after jumping over 158% on Friday.</li>
<li>Shineco, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SISI#NASDAQ">SISI</a>) dipped 28.2% to $0.2293 in pre-market trading after falling around 6% on Friday.</li>
<li>SS Innovations International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSII#NASDAQ">SSII</a>) declined 20.7% to $5.49 in pre-market trading after gaining around 42% on Friday.</li>
<li>Dragonfly Energy Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFLI#NASDAQ">DFLI</a>) declined 17.3% to $0.2079 in pre-market trading after gaining 15% on Friday.</li>
<li>Moving iMage Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#NASDAQ">MITQ</a>) dipped 17% to $0.7055 in pre-market trading. Moving iMage Technologies shares jumped 54% on Friday after the company announced a $9 million contract with a national cinema exhibition customer regarding the sale and installation of 150 Barco laser projections along with a range of MIT-manufactured equipment..</li>
<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) fell 16.8% to $1.09 in pre-market trading after the company announced it received a delisting notice from the Nasdaq.</li>
<li>Citius Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>) fell 16% to $2.21 in pre-market trading after jumping 70% on Friday.</li>
<li>Processa Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) fell 15.4% to $0.27 in pre-market trading after gaining 32% on Friday.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) fell 11.9% to $33.50 in pre-market trading after dipping 40% on Friday.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46023851/top-2-tech-stocks-that-could-sink-your-portfolio-in-june">Top 2 Tech Stocks That Could Sink Your Portfolio In June</a> </li>
</ul>
Photo via Shutterstock

CTOR

DFLI

DHAI

EXEL

HUSA

MITQ

MRIN

PCSA

SISI

SQNS

ZETA

Why Sequans Communications Shares Are Trading Higher By Over 42%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Innovative Eyewear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) stock rose 84.4% to $4.21 during Friday's regular session. The market value of their outstanding shares is at $7.0 million. </li>
<li>SS Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSII#NASDAQ">SSII</a>) stock moved upwards by 43.27% to $6.99. The market value of their outstanding shares is at $944.7 million. </li>
<li>Anbio Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNNN#NASDAQ">NNNN</a>) shares rose 41.89% to $16.4. The market value of their outstanding shares is at $507.3 million. </li>
<li>Processa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) shares increased by 32.68% to $0.32. The company's market cap stands at $2.8 million. </li>
<li>Citius Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>) stock moved upwards by 29.67% to $2.01. The market value of their outstanding shares is at $110.9 million. </li>
<li>Quantum BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNTM#NASDAQ">QNTM</a>) shares increased by 23.92% to $37.4. The market value of their outstanding shares is at $87.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>SeaStar Medical Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>) shares fell 66.7% to $0.32 during Friday's regular session. The market value of their outstanding shares is at $10.3 million. </li>
<li>Moleculin Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) shares declined by 48.89% to $0.3. The company's market cap stands at $8.2 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares declined by 43.12% to $36.03. The company's market cap stands at $824.3 million. </li>
<li>Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) stock decreased by 22.74% to $9.22. The company's market cap stands at $545.7 million. </li>
<li>Aptevo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) stock declined by 21.64% to $4.02. The company's market cap stands at $3.4 million. </li>
<li>Galectin Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GALT#NASDAQ">GALT</a>) shares fell 21.59% to $2.58. The market value of their outstanding shares is at $208.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APVO

CAPR

GALT

MBRX

12 Health Care Stocks Moving In Friday's Intraday Session

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Friday.
The Dow traded up 0.34% to 42,314.63 while the NASDAQ rose 0.28% to 19,600.90. The S&amp;P 500 also rose, gaining, 0.29% to 5,998.05.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45993572/top-2-industrials-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Industrials Stocks That May Fall Off A Cliff In Q2</a>
Leading and Lagging Sectors Real estate shares jumped by 0.7% on Friday.
In trading on Friday, health care stocks fell by 0.3%.
Top Headline
Accenture Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) posted better-than-expected third-quarter earnings.
The company reported quarterly earnings of $3.49 per share, topping the analyst consensus estimate of $3.31. The company reported sales of $17.7 billion, slightly exceeding the analyst consensus estimate of $17.30 billion. Sales increased 8% in U.S. dollars and 7% in local currency.
Accenture narrowed its fiscal year 2025 revenue growth outlook to 6%-7% (prior 5%-7%) in local currency. The company forecasts 2025 diluted earnings of $12.77-$12.89 (prior $12.55-$12.79) per share compared to the consensus of $12.75.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Wheeler Real Estate Investment Trust, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHLR#NASDAQ">WHLR</a>) shares shot up 159% to $8.85. On May 21, Wheeler Real Estate Investment Trust announced it will implement a 1-for-7 reverse stock split.</li>
<li>Shares of Dragonfly Energy Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFLI#NASDAQ">DFLI</a>) got a boost, surging 74% to $0.3796 after gaining 6% on Wednesday.</li>
<li>Innovative Eyewear, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) shares were also up, gaining 73% to $3.9502 after the company announced a partnership with Smartech Retail Group to showcase the Reebok Powered by Lucyd collection and other brands at the new Smartech location in New York City.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Nature Wood Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWGL#NASDAQ">NWGL</a>) shares dropped 59% to $2.2950 after surging over 142% on Wednesday.</li>
<li>Shares of Moleculin Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) were down 48% to $0.3040 as the company announced a $5.9 million public offering.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) was down, falling 48% to $32.99 after dipping over 18% on Wednesday.</li>
</ul>
Commodities In commodity news, oil traded down 0.5% to $74.71 while gold traded down 0.6% at $3,389.00.
Silver traded down 2.5% to $36.005 on Friday, while copper fell 0.3% to $4.8400.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.4%, while Spain's IBEX 35 Index rose 1%. London's FTSE 100 rose 0.1%, Germany's DAX 40 surged 1.3% and France's CAC 40 rose 0.6% during the session.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei falling 0.22%, Hong Kong's Hang Seng Index gaining 1.26%, China's Shanghai Composite falling 0.07% and India's BSE Sensex gaining 1.29%.
Economics
The Philadelphia Fed Manufacturing Index came in unchanged at -4.0 in June, versus market estimates of -1.
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/06/46024423/how-to-earn-500-a-month-from-commercial-metals-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Commercial Metals Stock Ahead Of Q3 Earnings</a> </li>
</ul>
Photo via Shutterstock

Equities

Eurozone

Commodities

NWGL

WHLR

Dow Surges Over 100 Points; Accenture Posts Upbeat Earnings

<h3>Gainers</h3>
<ul>
<li>Firefly Neuroscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIFF#NASDAQ">AIFF</a>) stock rose 19.6% to $3.59 during Friday's pre-market session. The company's market cap stands at $38.5 million. </li>
<li>Quantum BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNTM#NASDAQ">QNTM</a>) stock moved upwards by 18.45% to $35.75. The market value of their outstanding shares is at $87.7 million. </li>
<li>Processa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) shares moved upwards by 17.97% to $0.29. The market value of their outstanding shares is at $2.8 million. </li>
<li>Vivos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVOS#NASDAQ">VVOS</a>) stock moved upwards by 12.09% to $2.78. The market value of their outstanding shares is at $14.6 million. </li>
<li>Semler Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMLR#NASDAQ">SMLR</a>) shares moved upwards by 11.87% to $35.73. The company's market cap stands at $419.7 million. </li>
<li>Galmed Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLMD#NASDAQ">GLMD</a>) shares increased by 11.79% to $1.99. The market value of their outstanding shares is at $4.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares declined by 18.4% to $51.7 during Friday's pre-market session. The market value of their outstanding shares is at $824.3 million. </li>
<li>Terns Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TERN#NASDAQ">TERN</a>) shares decreased by 16.75% to $3.33. The market value of their outstanding shares is at $349.3 million. </li>
<li>Aptevo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) shares declined by 14.24% to $4.4. The company's market cap stands at $3.4 million. </li>
<li>Co-Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODX#NASDAQ">CODX</a>) stock declined by 11.66% to $0.25. The market value of their outstanding shares is at $9.4 million. </li>
<li>Insight Molecular (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMDX#NASDAQ">IMDX</a>) shares decreased by 11.4% to $2.8. The company's market cap stands at $90.3 million. </li>
<li>Opus Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRD#NASDAQ">IRD</a>) shares fell 10.75% to $0.83. The market value of their outstanding shares is at $55.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIFF

CODX

GLMD

IMDX

SMLR

TERN

VVOS

12 Health Care Stocks Moving In Friday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Friday.
Shares of Smith &amp; Wesson Brands Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) fell sharply in pre-market trading after the company reported <a href="https://www.benzinga.com/markets/earnings/25/06/46007280/smith-wesson-q4-earnings-revenue-eps-fall-short-of-estimates-as-demand-slips-headwinds-will-likely-persist">worse-than-expected fourth-quarter EPS and sales.</a>
Smith &amp; Wesson Brands reported fourth-quarter revenue of $140.8 million, missing analyst estimates of $152.41 million, according to Benzinga Pro. The company reported adjusted earnings of 20 cents per share in the fourth quarter, missing estimates of 23 cents per share.
Smith &amp; Wesson Brands shares dipped 12.6% to $9.51 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Regencell Bioscience Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares fell 16.2% to $52.96 in pre-market trading after dipping over 18% on Wednesday.</li>
<li>QuantaSing Group Ltd- ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSG#NASDAQ">QSG</a>) fell 12.1% to $11.86 in pre-market trading.</li>
<li>Aptevo Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) fell 11.9% to $4.52 in pre-market trading. Aptevo Therapeutics shares jumped 82% on Wednesday after the company announced clinical data from its ongoing Phase 1b/2 RAINIER trial evaluating mipletamig.</li>
<li>Capricor Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) fell 7.4% to $11.04 in pre-market trading. Capricor Therapeutics recently announced Orphan Drug designation for Becker Muscular Dystrophy.</li>
<li>Mesoblast Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) fell 6.5% to $10.94 in pre-market trading.</li>
<li>Diginex Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>) dropped 6.5% to $43.51 in pre-market trading.</li>
<li>Himalaya Shipping Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSHP#NASDAQ">HSHP</a>) declined 6.3% to $6.22 in pre-market trading.</li>
<li>AIRO Group Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRO#NASDAQ">AIRO</a>) fell 5.3% to $24.88 in pre-market trading.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45993572/top-2-industrials-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Industrials Stocks That May Fall Off A Cliff In Q2</a> </li>
</ul>
Photo via Shutterstock

AIRO

Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Comments

Regencell Bioscience

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL